Apremilast (CC-10004) 608141-41-9
Product Description
.cp_wz table {border-top: 1px solid #ccc;border-left:1px solid #ccc; } .cp_wz table td{border-right: 1px solid #ccc; border-bottom: 1px solid #ccc; padding: 5px 0px 0px 5px;} .cp_wz table th {border-right: 1px solid #ccc;border-bottom: 1px solid #ccc; padding: 5px 0px 0px 5px;}
Molecular Weight:
460.5 Apremilast (CC-10004) is a potent and orally active PDE4 and TNF-α inhibitor with IC50 of 74 nM and 77 nM, respectively.
Biological Activity
Apremilast is more potent for inhibition of PDE4 compared with cAMP or
cGMP hydrolysing enzymes from other PDE families. Apremilast displays a
broad pattern of anti-inflammatory activity in a variety of cell types,
inhibits TNF-α, IL-12 and IL-23 production, as well as NK and
keratinocyte responses. Apremilast is found to inhibit the
zymosan-induced PMN production of IL-8 with IC50 of 94 nM.
Apremilast
inhibits fMLF-induced PMN CD18 and CD11b expression with IC50 of 390 nM
and 74 nM, respectively, and inhibits fMLF-induced adhesion of PMN to
HUVECs with IC50 of 150 nM. Apremilast inhibits keratinocyte
TNF-αproduction, with no effect on keratinocyte cell viability as
measured by intracellular ATP levels.
Apremilast is stable in the presence of human microsomes (t1/2 > 60
min). It is 90% protein bound in human plasma. Oral and intravenous
administration of it in female rats showed that it have good
pharmacokinetics with low clearance, a moderate volume of distribution,
and a 64% oral bioavailability.
In a LPS-induced TNF-αinhibition model
in rats, examined the TNF-α inhibitory ability of Apremilast in vivo,
and the ED50 is determined to be 0.03 mg/kg. In another LPS-induced
neutrophilia model in rats, Apremilast exhibited an ED50 range from 0.3
mg/kg to 0.9 mg/kg.
Contact us if you need more details on 608141-41-9. We are ready to answer your questions on packaging, logistics, certification or any Other aspects about Apremilast 608141-41-9、608141-41-9 CC-10004. If these products fail to match your need, please contact us and we would like to provide relevant information.
Molecular Weight:
460.5 Apremilast (CC-10004) is a potent and orally active PDE4 and TNF-α inhibitor with IC50 of 74 nM and 77 nM, respectively.
Biological Activity
Apremilast is more potent for inhibition of PDE4 compared with cAMP or
cGMP hydrolysing enzymes from other PDE families. Apremilast displays a
broad pattern of anti-inflammatory activity in a variety of cell types,
inhibits TNF-α, IL-12 and IL-23 production, as well as NK and
keratinocyte responses. Apremilast is found to inhibit the
zymosan-induced PMN production of IL-8 with IC50 of 94 nM.
Apremilast
inhibits fMLF-induced PMN CD18 and CD11b expression with IC50 of 390 nM
and 74 nM, respectively, and inhibits fMLF-induced adhesion of PMN to
HUVECs with IC50 of 150 nM. Apremilast inhibits keratinocyte
TNF-αproduction, with no effect on keratinocyte cell viability as
measured by intracellular ATP levels.
Apremilast is stable in the presence of human microsomes (t1/2 > 60
min). It is 90% protein bound in human plasma. Oral and intravenous
administration of it in female rats showed that it have good
pharmacokinetics with low clearance, a moderate volume of distribution,
and a 64% oral bioavailability.
In a LPS-induced TNF-αinhibition model
in rats, examined the TNF-α inhibitory ability of Apremilast in vivo,
and the ED50 is determined to be 0.03 mg/kg. In another LPS-induced
neutrophilia model in rats, Apremilast exhibited an ED50 range from 0.3
mg/kg to 0.9 mg/kg.
Contact us if you need more details on 608141-41-9. We are ready to answer your questions on packaging, logistics, certification or any Other aspects about Apremilast 608141-41-9、608141-41-9 CC-10004. If these products fail to match your need, please contact us and we would like to provide relevant information.
Product Categories : Metabolism > PDE Inhibitor
Other Products
Hot Products
Astragaloside AChlortetracycline HCl 64-72-2Paclitaxel 33069-62-4Dexamethasone Acetate 1177-87-3Dinaciclib (SCH727965) 779353-01-4CHIR-124 405168-58-3Ro3280 1062243-51-9TAME 901-47-3CCG-1423 285986-88-110058-F4 403811-55-2Dabigatran (BIBR 953) 211914-51-1H 89 2HCl 130964-39-5T0901317 293754-55-9Aprepitant 170729-80-3Turofexorate Isopropyl (XL335) 629664-81-9BMS-378806 357263-13-9